The article informs that Onyx Pharmaceuticals Inc. has received approval for Kyprolis from the U.S. Food and Drug Administration. It further informs that Kyprolis is used for the treatment of multiple myeloma. It mentions that Multiple Myeloma Research Foundation has collaborated with Onyx for advancing the clinical development of Kyprolis.
No Comments.